116 related articles for article (PubMed ID: 38902966)
1. Enhanced stiffness in peri-cancerous tissue: a marker of poor prognosis in papillary thyroid carcinoma with lymph node metastasis.
Hu L; Ye L; Pei C; Sun C; Zhang C; Jiang F; He N; Lv W
Oncologist; 2024 Jun; ():. PubMed ID: 38902966
[TBL] [Abstract][Full Text] [Related]
2. Pathomics and single-cell analysis of papillary thyroid carcinoma reveal the pro-metastatic influence of cancer-associated fibroblasts.
Wang Y; Li X; Gang Q; Huang Y; Liu M; Zhang H; Shen S; Qi Y; Zhang J
BMC Cancer; 2024 Jun; 24(1):710. PubMed ID: 38858612
[TBL] [Abstract][Full Text] [Related]
3. Single-cell and bulk RNA sequencing reveal heterogeneity and diagnostic markers in papillary thyroid carcinoma lymph-node metastasis.
Lu DN; Zhang WC; Lin YZ; Jiang HY; He R; Li SL; Zhang YN; Shao CY; Zheng CM; Xu JJ; Ge MH
J Endocrinol Invest; 2024 Jun; 47(6):1513-1530. PubMed ID: 38146045
[TBL] [Abstract][Full Text] [Related]
4. Potential diagnostic of lymph node metastasis and prognostic values of TM4SFs in papillary thyroid carcinoma patients.
Wang K; Li H; Zhao J; Yao J; Lu Y; Dong J; Bai J; Liao L
Front Cell Dev Biol; 2022; 10():1001954. PubMed ID: 36568979
[No Abstract] [Full Text] [Related]
5. Relationship between subgroups of central and lateral lymph node metastasis in clinically node-negative papillary thyroid carcinoma.
Zhou J; Li DX; Gao H; Su XL
World J Clin Cases; 2022 Apr; 10(12):3709-3719. PubMed ID: 35647144
[TBL] [Abstract][Full Text] [Related]
6. Thymosin beta 10 correlates with lymph node metastases of papillary thyroid carcinoma.
Zhang XJ; Su YR; Liu D; Xu DB; Zeng MS; Chen WK
J Surg Res; 2014 Dec; 192(2):487-93. PubMed ID: 24974154
[TBL] [Abstract][Full Text] [Related]
7. Influence of Obesity Parameters on Different Regional Patterns of Lymph Node Metastasis in Papillary Thyroid Cancer.
Wu WX; Feng JW; Ye J; Qi GF; Hong LZ; Hu J; Liu SY; Jiang Y; Qu Z
Int J Endocrinol; 2022; 2022():3797955. PubMed ID: 36389127
[TBL] [Abstract][Full Text] [Related]
8. Correlation of lymph node metastasis with contrast-enhanced ultrasound features, microvessel density and microvessel area in patients with papillary thyroid carcinoma.
Liu Z; Li C
Clin Hemorheol Microcirc; 2022; 82(4):361-370. PubMed ID: 36213988
[TBL] [Abstract][Full Text] [Related]
9. Integrated microRNA, gene expression and transcription factors signature in papillary thyroid cancer with lymph node metastasis.
Ab Mutalib NS; Othman SN; Mohamad Yusof A; Abdullah Suhaimi SN; Muhammad R; Jamal R
PeerJ; 2016; 4():e2119. PubMed ID: 27350898
[TBL] [Abstract][Full Text] [Related]
10. Tumor-Infiltrating Immune Cell Landscapes in the Lymph Node Metastasis of Papillary Thyroid Cancer.
Amanullah M; Pan M; Lu K; Pan X; Lu Y; Luo D; Liu P
Curr Oncol; 2023 Feb; 30(3):2625-2641. PubMed ID: 36975413
[TBL] [Abstract][Full Text] [Related]
11. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.
Saiselet M; Gacquer D; Spinette A; Craciun L; Decaussin-Petrucci M; Andry G; Detours V; Maenhaut C
BMC Genomics; 2015 Oct; 16():828. PubMed ID: 26487287
[TBL] [Abstract][Full Text] [Related]
12. Identification of biomarkers associated with cervical lymph node metastasis in papillary thyroid carcinoma: Evidence from an integrated bioinformatic analysis.
Zhang Z; Zhao S; Wang K; Shang M; Chen Z; Yang H; Chen Y; Chen B
Clin Hemorheol Microcirc; 2021; 78(2):117-126. PubMed ID: 33554894
[TBL] [Abstract][Full Text] [Related]
13. Proteomics study of serum exosomes from papillary thyroid cancer patients.
Luo D; Zhan S; Xia W; Huang L; Ge W; Wang T
Endocr Relat Cancer; 2018 Oct; 25(10):879-891. PubMed ID: 29895528
[TBL] [Abstract][Full Text] [Related]
14. BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer.
Tao Y; Wang F; Shen X; Zhu G; Liu R; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Zhao S; Wang Y; Xing M
J Clin Endocrinol Metab; 2021 Oct; 106(11):3228-3238. PubMed ID: 34273152
[TBL] [Abstract][Full Text] [Related]
15. Integrated Characterization of MicroRNA and mRNA Transcriptome in Papillary Thyroid Carcinoma.
Mohamad Yusof A; Jamal R; Muhammad R; Abdullah Suhaimi SN; Mohamed Rose I; Saidin S; Ab Mutalib NS
Front Endocrinol (Lausanne); 2018; 9():158. PubMed ID: 29713312
[TBL] [Abstract][Full Text] [Related]
16. Expression profiling and bioinformatics analysis of serum exosomal circular RNAs in lymph node metastasis of papillary thyroid carcinoma.
Peng H; Zhu Z; Xing J; Xu Q; Man C; Wang S; Liu Y; Zhang Z
J Biomed Res; 2024 May; ():1-15. PubMed ID: 38812291
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of contrast-enhanced ultrasonography in the preoperative evaluation of lymph node metastasis in papillary thyroid carcinoma: a single-center retrospective study.
Yang Z; Wang X; Tao T; Zou J; Qiu Z; Wang L; Du H; Chen N; Yin X
BMC Surg; 2023 Oct; 23(1):325. PubMed ID: 37875825
[TBL] [Abstract][Full Text] [Related]
18. Fasting serum glucose and lymph node metastasis in non-diabetic PTC patients: a 10-Year multicenter retrospective study.
Liu Y; Gong J; Huang Y; Xing S; Chen L; Yi T; Wang Z; Lv Y
J Cancer; 2022; 13(8):2673-2682. PubMed ID: 35711846
[No Abstract] [Full Text] [Related]
19. A protective factor against lymph node metastasis of papillary thyroid cancer: Female gender.
Shi P; Yang D; Liu Y; Zhao Z; Song J; Shi H; Wu Y; Jing S
Auris Nasus Larynx; 2023 Jun; 50(3):440-449. PubMed ID: 36253315
[TBL] [Abstract][Full Text] [Related]
20. Lymph node metastasis in young and middle-aged papillary thyroid carcinoma patients: a SEER-based cohort study.
Liu Y; Wang Y; Zhao K; Li D; Chen Z; Jiang R; Wang X; He X
BMC Cancer; 2020 Mar; 20(1):181. PubMed ID: 32131769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
